Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig T Jordan

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Leukemia|December 19, 2025
Targeting IL-1/IRAK1/4 signaling in acute myeloid leukemia stem cells following treatment and relapseTzu-Chieh Ho, Mark W LaMere, Hiroki Kawano, et al.
Nature|July 20, 2010
Regulation of myeloid leukaemia by the cell-fate determinant MusashiTakahiro Ito, Hyog Young Kwon, Bryan Zimdahl, et al.
Cell Stem Cell|June 19, 2018
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem CellsShanshan Pei, Mohammad Minhajuddin, Biniam Adane, et al.
Blood Advances|October 25, 2019
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, et al.
JCO Clinical Cancer Informatics|December 2, 2025
Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and AzacitidineNazmul Islam, Justin L Dale, Jamie S Reuben, et al.
Haematologica|April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemiaJonathan A Gutman, Amanda Winters, Andrew Kent, et al.
Haematologica|June 27, 2024
Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemiaMohd Minhajuddin, Amanda Winters, Haobin Ye, et al.
Cell Reports|April 4, 2019
The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem CellsBiniam Adane, Haobin Ye, Nabilah Khan, et al.
The Journal of Biological Chemistry|October 4, 2013
Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cellsShanshan Pei, Mohammad Minhajuddin, Kevin P Callahan, et al.
Cell Stem Cell|August 22, 2020
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Daniel A Pollyea, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Leukemia|December 19, 2025
Targeting IL-1/IRAK1/4 signaling in acute myeloid leukemia stem cells following treatment and relapseTzu-Chieh Ho, Mark W LaMere, Hiroki Kawano, et al.
Nature|July 20, 2010
Regulation of myeloid leukaemia by the cell-fate determinant MusashiTakahiro Ito, Hyog Young Kwon, Bryan Zimdahl, et al.
Cell Stem Cell|June 19, 2018
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem CellsShanshan Pei, Mohammad Minhajuddin, Biniam Adane, et al.
Blood Advances|October 25, 2019
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, et al.
JCO Clinical Cancer Informatics|December 2, 2025
Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and AzacitidineNazmul Islam, Justin L Dale, Jamie S Reuben, et al.
Haematologica|April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemiaJonathan A Gutman, Amanda Winters, Andrew Kent, et al.
Haematologica|June 27, 2024
Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemiaMohd Minhajuddin, Amanda Winters, Haobin Ye, et al.
Cell Reports|April 4, 2019
The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem CellsBiniam Adane, Haobin Ye, Nabilah Khan, et al.
The Journal of Biological Chemistry|October 4, 2013
Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cellsShanshan Pei, Mohammad Minhajuddin, Kevin P Callahan, et al.
Cell Stem Cell|August 22, 2020
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem CellsCourtney L Jones, Brett M Stevens, Daniel A Pollyea, et al.
Pageof 17